Patricia Larson, MD
Infectious Disease · Elk Grove Village, ILNPI 1750300091
Payments from drug & device makers
Across 106 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Melinta Therapeutics, LLC$508
- Smith+Nephew$483
- Insmed, Inc.$306
- Merck$173
- Paratek Pharmaceuticals, Inc.$163
- La Jolla Pharmaceutical Company$96
- plus $243 from 7 others
What the payments were for
- Food & beverage$1,89496%
- Education$784%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Melinta Therapeutics, LLC | 37 | $508 |
| Smith+Nephew | 21 | $483 |
| Insmed, Inc. | 14 | $306 |
| Merck | 10 | $173 |
| Paratek Pharmaceuticals, Inc. | 8 | $163 |
| La Jolla Pharmaceutical Company | 4 | $96 |
| Shionogi Inc | 4 | $82 |
| Astellas Pharma US Inc | 2 | $48 |
| Shire North American Group Inc | 2 | $37 |
| Dentsply Sirona Inc | 1 | $23 |
| KCI USA, Inc. | 1 | $19 |
| Organogenesis Inc. | 1 | $18 |
| AbbVie | 1 | $16 |
How this compares
$1,972 in reported general payments places this provider in the 75th percentile of 368 infectious disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 23 | $16,019 |
| Vancomycin Hcl | 22 | $2,548 |
| CeftriaxoneCeftriaxone Sodium | 18 | $1,000 |
| Doxycycline Hyclate | 11 | $158 |
| Amoxicillin | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Elk Grove Village
- Kathleen MullaneChicago$4.4M
- Gregory HuhnChicago$3M
- Catherine CreticosChicago$1.7M
- Babafemi TaiwoChicago$1.4M
- Shivanjali ShankaranChicago$1.1M
- Frank PalellaChicago$987K
- Kamaljit SinghChicago$971K
- Richard NovakChicago$960K
- Renslow ShererChicago$821K
- Russell PetrakBurr Ridge$623K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.